Cover Story Featured Article Product Launch Regulatory Authorization Paw Prosper Brings Elvation Shockwave to North America Strategic Partnership Paw Prosper has expanded its partnership with Elvation Medical, becoming the exclusive home and commercial partner for Elvation VET Shockwave Th...
Quick Takeaways: Why It Matters? Paw Prosper’s exclusive US and Canada partnership with Elvation Medical expands its veterinary rehabilitation portfolio with the PiezoWave2T VET shockwave system, strengthening its position in both equine and small-animal markets. By c...
Quick Takeaways: Why It Matters? The UK launch of Scovella (velagliflozin oral solution) creates the first licensed, equine‑specific treatment for hyperinsulinemia, directly targeting the main driver behind most laminitis cases and shifting management from off‑la...
Cover Story Featured Article Product Launch Facility Expansion SUPRDOG Opens Waitlist for AI-Powered Biological Intelligence Platform for Dogs Product Launch SUPRDOG has opened the waitlist for an AI-enabled biological intelligence platform designed to h...
Dechra Launches Domidine Equine Sedative in the US Quick Takeaways: Why It Matters? Dechra’s US launch of Domidine (detomidine) adds a generic, cost‑effective alpha‑2 agonist to the equine sedation market, giving veterina...
Featured Report Top 20 Companies Shaping the Future of Animal Nutrition in 2026 Featured Article Did a Spider Bite Your Pet? Signs You Shouldn’t Ignore Product Launch JustFoodForDogs Launches New Digestive Care Diet Strategic Collaboration Petwealth and Kennel Connection Explore Proactive ...
Cover story Featured Article Regulatory Authorization Product Launch Licensing Deal Strategic Partnership Boehringer Ingelheim Acquires Evax to Advance Therapeutic Vaccines for Equine Allergies Strategic Acquisition BI has acquired Evax AG, a Swiss biotechnology company developing therapeu...
Quick Takeaways: Why It Matters? By putting TRUFORMA analyzers in equine clinics at no cost and offering free PPID testing cartridges to eligible Boehringer Ingelheim customers, the program makes it much easier and faster for vets to diagnose and monitor Cus...
Quick Takeaways: Why It Matters? Boehringer Ingelheim’s purchase of Evax gives it a promising new way to treat common horse allergies with longer‑lasting vaccines instead of short‑term symptom relief, which could mean fewer vet visits and better outcomes for owners. If the approach works a...
Featured Article Cover Story Research Development Product Launch Clinical Trial Results The Farmer’s Dog to Acquire Woof, Expanding Into Canine Wellness and Enrichment Strategic Acquisition The Farmer’s Dog will acquire Woof, the pet wellness company behind functional enrichment products s...
